Amphastar Prescribed drugs (AMPH) got here out with quarterly earnings of $0.07 per share, beating the Zacks Consensus Estimate of $0.05 per share. This compares to earnings of $0.13 per share a 12 months in the past. These figures are adjusted for non-recurring gadgets.
This quarterly report represents an earnings shock of 40%. 1 / 4 in the past, it was anticipated that this specialty pharmaceutical firm would submit earnings of $0.08 per share when it really produced earnings of $0.10, delivering a shock of 25%.
During the last 4 quarters, the corporate has surpassed consensus EPS estimates 4 occasions.
Amphastar, which belongs to the Zacks Medical – Generic Medication trade, posted revenues of $83.38 million for the quarter ended December 2019, surpassing the Zacks Consensus Estimate by 3.87%. This compares to year-ago revenues of $89.69 million. The corporate has topped consensus income estimates 4 occasions during the last 4 quarters.
The…